Chemical Name:[(1S)-1-[[(7-Bromo-1,2,3,4-tetrahydro-2,3-dioxo-5-quino
xalinyl)methyl]amino]ethyl]phosphonic acid
hydrochloride
Biological Activity:
Potent and selective NMDA antagonist that acts
through the glycine site (IC50 = 5 nM). Displays > 500-fold
selectivity over kainate and AMPA receptors (IC50 values are 2.7 and
3 μM
respectively). Anticonvulsant in vivo following systemic administration.
Aubersonet al (1999)
N-phosphonoalkyl-5-aminomethylquinoxaline-2,3-diones: in vivo active AMPA and
NMDA(glycine) antagonists. Bioorg.Med.Chem.Lett. 9 249. Ametameyet al (2000) Synthesis, radiolabelling and biological characterization
of (D)-7-iodo-N-(1-phosphonoethyl)l-5-aminomethylquinoxaline-2,3-dione,
a glycine-binding site antagonist of NMDA receptors. Bioorg.Med.Chem.Lett.
10 75.
Displays 26-fold and > 440-fold selectivity over kainate and NMDA receptors respectively. Neuro-protective; delays neuronal death in a global ischaemia model and cerebral infarction in a focal ischaemia model.